3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
6
Pancreatic Neoplasms
5
Motor Activity
3
Colonic Neoplasms
3
Prostatic Neoplasms
2
Uterine Cervical Neoplasms
1
Rectal Neoplasms
1
Pancreatic Adenocarcinoma
1
Muscular Diseases
1
Head and Neck Neoplasms
1
Gastric Adenocarcinoma
1
Cholangiocarcinoma
1
Cachexia
1
Breast Neoplasms
1
Interventions
Gemcitabine
13
Albumin-Bound Paclitaxel
8
Taxes
6
130-nm albumin-bound paclitaxel
6
Fluorouracil
5
Oxaliplatin
4
dehydroftorafur
3
Radiotherapy, Intensity-Modulated
3
Radiotherapy
3
Leucovorin
3
Irinotecan
3
Losartan
2
Cisplatin
2
tocilizumab
1
selicrelumab
1
niraparib
1
irinotecan sucrosofate
1
indusatumab
1
folfirinox
1
durvalumab
1
cobimetinib
1
atezolizumab
1
X-Rays
1
Tiragolumab
1
Surgical Procedures, Operative
1
Standard of Care
1
Specimen Handling
1
S 1 (combination)
1
Resistance Training
1
Radiotherapy, Image-Guided
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pancreatic Adenocarcinoma
×
Resistance Training
×
Gastrointestinal
×
Clear all
NCT02680990
2018-02-28
REACT
Milton S. Hershey Medical Center
Phase NA
Completed
14 enrolled